Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Nuonen Biotechnology is a Chinese life sciences company based in the Haikou National High-tech Zone, specializing in regenerative medicine and cell-based therapies. The company focuses on the research, development, and clinical application of mesenchymal stem cells (MSCs) and immune cell technologies, such as NK and CIK cells. Nuonen Biotechnology operates advanced laboratory facilities for cell storage, processing, and quality control to support personalized medicine initiatives. Their mission centers on leveraging biotechnology to address chronic diseases, aging-related conditions, and oncology through innovative cellular interventions. The company is strategically positioned to benefit from the medical innovation policies in the Hainan Free Trade Port.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Nuonen Biotechnology.